Oragenics Inc.
$0.49
Market Cap
$2.25M
Shares Outstanding
4.5M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Jul 3, 2003
Round Lot
100
Locale
US
Day Open
$0.49
Day High
$0.50
Day Low
$0.48
Volume
25.5K
VWAP
$0.49
Prev Close
$0.50
Transactions
--
Acc. Volume
--
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
Oragenics Inc. (OGEN) closed the 2026-09-15 session at $0.49, down 2.28% versus the previous close (-0.01). The stock opened at $0.49 and traded between $0.48 and $0.50 during that session. Session trading volume was 26K shares. The volume-weighted average price (VWAP) is $0.49.
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
Oragenics Inc. has a market capitalization of $2.3 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. OGEN is listed on the XASE exchange. The company employs approximately 3 people. Oragenics Inc. is headquartered in LAKEWOOD RANCH, FL. The recorded listing date is 2003-07-03.
On this page you can find market OGEN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.